Byrne Asset Management »

Regeneron Pharmaceuticals shares owned by Byrne Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Byrne Asset Management from 13F filings

Historical chart of Byrne Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Byrne Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $40k 41 962.49
2023-12-31 $36k 41 874.37
2023-09-30 $34k 41 829.27
2023-06-30 $29k 41 707.32
2023-03-31 $34k 41 829.27
2022-12-31 $30k 41 721.49
2022-09-30 $33k 48 687.50
2022-06-30 $28k 48 583.33
2022-03-31 $34k 48 708.33
2021-12-31 $34k 54 629.63